Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Cash & Current Investments (2016 - 2025)

Dexcom (DXCM) has disclosed Cash & Current Investments for 16 consecutive years, with $917.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 583.83% to $917.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $917.7 million through Dec 2025, up 583.83% year-over-year, with the annual reading at $917.7 million for FY2025, 583.83% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $917.7 million at Dexcom, down from $1.8 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $1.8 billion in Q3 2025, with the low at $134.2 million in Q4 2024.
  • Average Cash & Current Investments over 5 years is $878.6 million, with a median of $793.3 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments tumbled 76.3% in 2024, then skyrocketed 583.83% in 2025.
  • Over 5 years, Cash & Current Investments stood at $1.1 billion in 2021, then tumbled by 38.98% to $642.3 million in 2022, then decreased by 11.83% to $566.3 million in 2023, then tumbled by 76.3% to $134.2 million in 2024, then surged by 583.83% to $917.7 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $917.7 million, $1.8 billion, and $1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.